Stay updated with breaking news from Cell Microtechnologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new type of bioreactor that can grow human veins in the lab has been developed by CSEM and ClexBio, a Nordics-based startup specialized in regenerative medicine.
ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins in the lab. The joint project has received over two million Swiss francs in funding from the Research Council of Norway and aims to produce an entirely new type of vein graft that could improve the lives of the millions of people suffering from deep venous insufficiency.
ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins in the lab.